MRP8/14 and neutrophil elastase for predicting treatment response and occurrence of flare in patients with juvenile idiopathic arthritis.

导出 OA

翻译打印收藏纠错

第一作者： Anouk M,Barendregt

第一单位： Department of Paediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam.

作者： Anouk M,Barendregt ^[1] ; Saskia R,Veldkamp ^[2] ; Petra C E,Hissink Muller ^[1] ; Annemarie,van de Geer ^[3] ; Cathelijn,Aarts ^[4] ; E Charlotte,van Gulik ^[4] ; Marco W,Schilham ^[1] ; Christoph,Kessel ^[2] ; Mischa P,Keizer ^[3] ; Robert,Hemke ^[5] ; Amara,Nassar-Sheikh Rashid ^[4] ; Koert M,Dolman ^[2] ; Dieneke,Schonenberg-Meinema ^[1] ; Rebecca,Ten Cate ^[6] ; J Merlijn,van den Berg ^[7] ; Mario,Maas ^[1] ; Taco W,Kuijpers ^[3]

作者单位： Department of Paediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam. ^[1] Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam. ^[2] Department of Paediatric Rheumatology, Leiden University Medical Center, Leiden. ^[3] Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands. ^[4] Department of Paediatric Rheumatology and Immunology, University Children's Hospital Muenster, Muenster, Germany. ^[5] Department of Paediatric Rheumatology, Reade, Amsterdam. ^[6] Department of Paediatrics, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. ^[7]

关键词 MRP8/14 S100A8/A9 biomarkers calprotectin disease activity flare juvenile idiopathic arthritis neutrophil elastase prediction treatment response